Stay updated on ADVANCE-2 Pimavanserin Clinical Trial
Sign up to get notified when there's something new on the ADVANCE-2 Pimavanserin Clinical Trial page.

Latest updates to the ADVANCE-2 Pimavanserin Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn administrative revision entry v3.4.2 was added to the study history. The prior v3.4.1 notice is removed from the current view.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide notice about government funding affecting data updates was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedUI updates include a glossary toggle and color-coded highlights (green for additions, red for deletions) in the record history. The revision label was updated to v3.4.0 (removing v3.3.4) and there is a capitalization change for 'No FEAR Act Data'.SummaryDifference0.8%

- Check35 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check86 days agoChange DetectedA new history version, v3.3.2, was added and the previous version, v3.3.1, removed from the list. This reflects a routine update to the record history display on the page.SummaryDifference0.1%

Stay in the know with updates to ADVANCE-2 Pimavanserin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE-2 Pimavanserin Clinical Trial page.